Works matching IS 19450877 AND DT 2009 AND VI 2 AND IP 101

Results: 4
    1
    2
    3

    EGFR Signaling Through an Akt-SREBP-1-Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy.

    Published in:
    Science Signaling, 2009, v. 2, n. 101, p. 1, doi. 10.1126/scisignal.2000446
    By:
    • Deliang Guo;
    • Prins, Robert M.;
    • Dang, Julie;
    • Daisuke Kuga;
    • Akio Iwanami;
    • Soto, Horacio;
    • Lin, Kelly Y.;
    • Huang, Tiffany T.;
    • Akhavan, David;
    • Hock, M. Benjamin;
    • Shaojun Zhu;
    • Kofman, Ava A.;
    • Bensinger, Steve J.;
    • Yong, William H.;
    • Vinters, Harry V.;
    • Horvath, Steve;
    • Watson, Andrew D.;
    • Kuhn, John G.;
    • Robins, H. Ian;
    • Mehta, Minesh P.
    Publication type:
    Article
    4